Sleep, health conditions and quality of life among professors at higher education institutions in Brazil: baseline data from the RESPIRA cohort.

Publication date: Jul 03, 2025

The intensification of teaching work, especially after the COVID-19 pandemic, raises questions about professors’ health. RESPIRA is a Brazilian prospective cohort study conducted to investigate daytime sleepiness, the predisposition to obstructive sleep apnea (OSA), psychosocial aspects, physical activity and quality of life in professors, with six-month and 12-month follow-up assessments. A total of 954 professors from public higher education institutions in Brazil were included at baseline from May to December 2022. Daytime sleepiness (Epworth Sleepiness Scale), predisposition to obstructive sleep apnea (Stop-Bang questionnaire), psychosocial aspects (COPSOQ II-Br), physical activity level (IPAQ-short version) and quality of life (WHOQOL-bref) were investigated, and descriptive analysis was performed. The largest portions of the professors were male (52%), residents of the state of ScE3o Paulo (24%), public servants (97%) and most had a PhD (89%). Around 30% had excessive daytime sleepiness and 40% had intermediate to high risk for OSA predisposition. Most professors were at risk due to stress (64%), burnout (63%), emotional work demands (51%) and work-family conflict (46%). Regarding physical activity level, 39% were categorized as active and 59% were overweight/obese. ‘Social relationships’ was the most affected domain of quality of life (62%); ‘sexual activity’ (3. 16 +/- 1. 09), ‘sleep and rest’ (3. 20 +/- 1. 07) and ‘participation in and opportunities for recreation/leisure activities’ (3. 24 +/- 0. 88) were the most compromised facets. The baseline data suggest the need to recognize and address psychological distress and sleep disorders in the teaching population at public higher education institutions in Brazil. The findings also highlight the importance of strategies for promoting opportunities for leisure and rest as well as the need to ensure adequate sleep, weight, sexual satisfaction and mental health.

Open Access PDF

Concepts Keywords
Brazil Adult
December Brazil
Overweight COVID-19
Professors Exercise
Sleepiness Faculty
Female
Health Status
Humans
Male
Mental health
Middle Aged
Obstructive Sleep Apnea
Occupational health
Physical activity
Prospective Studies
Quality of Life
Quality of life
Sleep
Sleep Apnea, Obstructive
Sleepiness
Surveys and Questionnaires
Universities

Semantics

Type Source Name
disease IDO quality
disease MESH COVID-19 pandemic
disease MESH daytime sleepiness
disease MESH obstructive sleep apnea
disease MESH Sleepiness
disease MESH burnout
disease MESH overweight
disease MESH psychological distress
disease MESH sleep disorders
pathway REACTOME Reproduction
disease MESH sleep apnea
drug DRUGBANK Alendronic acid
drug DRUGBANK Trihexyphenidyl
disease IDO production
disease MESH sedentary lifestyle
disease MESH insufficient sleep
disease MESH anxiety
disease MESH mental fatigue
disease MESH insomnia
disease MESH back pain
disease MESH voice disorders
disease MESH high blood pressure
disease MESH coronary artery disease
disease MESH dyspnea
disease IDO symptom
disease MESH syndrome
disease MESH noncommunicable diseases
disease MESH chronic obstructive pulmonary disease
disease MESH diabetes mellitus
disease MESH chronic kidney disease
disease MESH cardiovascular diseases
disease MESH myocardial infarction
disease MESH congestive heart failure
disease MESH obesity
disease MESH chronic diseases
disease MESH myocardial ischemia
disease MESH stroke
disease MESH lifestyle
disease MESH weight gain
disease MESH morbidity
disease MESH premature aging
drug DRUGBANK Etoperidone
drug DRUGBANK Trestolone
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO blood
drug DRUGBANK Ilex paraguariensis leaf
drug DRUGBANK Methionine
disease IDO country
drug DRUGBANK Tretamine
disease MESH anxiety disorder
disease MESH low back pain
disease MESH depression
disease IDO process
disease MESH abdominal obesity
disease MESH weight loss
disease IDO disposition
drug DRUGBANK Ademetionine
drug DRUGBANK Ribostamycin
disease MESH Health Status

Original Article

(Visited 5 times, 1 visits today)